- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
- Video and telephone consultations
- Home chemotherapy
After qualifying and working as a doctor in the UK I commenced my training in medical oncology in New Zealand, and then completed training at the Christie Hospital in Manchester, a leading cancer centre. I also carried out a period of 3 years research as a Cancer Research UK Clinical Fellow studying Immunotherapy of Cancer at the Paterson Institute for Cancer Research. This led to the award of a higher degree (MD) by the University of Manchester.
I am currently working at the Bristol Cancer Institute where I carry out a busy clinical practice. I am also network lead for lung cancer, Chief Clinical Information Officer, and previously lead for chemotherapy. I am a board member for the British Sarcoma Group. As well as providing care for patients with cancer, I supervise and teach oncology trainees, junior doctors and medical students.
Areas of interest
Lung cancer; Mesothelioma; Sarcoma; Gastrointestinal stromal tumour (GIST)
Current NHS consultant posts held
Medical Oncologist at the Bristol Cancer Institute, Bristol Haematology & Oncology Centre
Clinical trials involving new treatments for the tumour types I treat. Previous research into cancer vaccines and immunotherapy.
Tennis, cycling, golf, photography, Digital Health.
Oncology Advisor to Doctors.net
American Society of Clinical Oncology Merit Award for my research project
Judson I, Morden JP, Kilburn L, Leahy M, Benson C, Bhadri V, Campbell-Hewson Q, Cubedo R, Dangoor A, Fox L, Hennig I, Jarman K, Joubert W, Kernaghan S, López Pousa A, McNeil C, Seddon B, Snowdon C, Tattersall M, Toms C, Martinez Trufero J, Bliss JM. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial. Lancet Oncol. 2019 Jul;20(7):1023-1034. doi: 10.1016/S1470-2045(19)30215-3. Epub 2019 May 31.
de Fonseka D, Morley A, Stadon L, Keenan E, Walker S, Smith S, Harvey JE, Cox RA, Dangoor A, Comins C, Rogers C, Edey A, Addeo A, Maskell NA. Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial. Trials. 2018 Aug 29;19(1):467.
Talbot T, Dangoor A, Shah R, Naik J, Talbot D, Lester JF, Cipelli R, Hodgson M, Patel A, Summerhayes M, Newsom-Davis T. The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study. Lung Cancer. 2017 Nov;113:115-120.
Judson I, Bulusu R, Seddon B, Dangoor A, Wong N, Mudan S. UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST). Clin Sarcoma Res. 2017 Apr 21;7:6. doi: 10.1186/s13569-017-0072-8. eCollection 2017
Dangoor A, Seddon B, Gerrand C, Grimer R, Whelan J, Judson I. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res. 2016 Nov 15;6:20. eCollection 2016
Baird R, Banks I, Cameron D, Chester J, Earl H, Flannagan M, Januszewski A, Kennedy R, Payne S, Samuel E, Taylor H, Agarwal R, Ahmed S, Archer C, Board R, Carser J, Copson E, Cunningham D, Coleman R, Dangoor A, Dark G, Eccles D, Gallagher C, Glaser A, Griffiths R, Hall G, Hall M, Harari D, Hawkins M, Hill M, Johnson P, Jones A, Kalsi T, Karapanagiotou E, Kemp Z, Mansi J, Marshall E, Mitchell A, Moe M, Michie C, Neal R, Newsom-Davis T, Norton A, Osborne R, Patel G, Radford J, Ring A, Shaw E, Skinner R, Stark D, Turnbull S, Velikova G, White J, Young A, Joffe J, Selby P. An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience. 2016 Jan 5;10:608. doi: 10.3332/ecancer.2016.608. eCollection 2016
Plummer C, Dangoor A. The trumpet's blown pupil. Med J Aust. 2015 May 18;202(9):497.
Courses offered to GPs
Happy to be contacted to arrange GP education sessions on cancer management
- Batchelor of Medical Science (Honours) University of Nottingham 1991
- Batchelor of Medicine & Bachelor of Surgery University of Nottingham 1993
- Member of Royal College of Physicians RCP (UK) 1999
- MD (Doctor of Medicine) University of Manchester 2011
- Postgraduate Diploma in Digital Health Leadership Imperial College London 2019
Reference number 4020486
Professional bodies (positions held - last 3 yrs)
- Executive Committee Member Association of Cancer Physicians 2018
Details of entry to specialist register
- CCT Medical Oncology , 2008
Affiliations / memberships
Board Member, British Sarcoma Group
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Patients all receive emergency contact numbers from either the Spire Oncology team or Healthcare at Home.
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)
GenesisCare, Bristol (1-5)
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-28 days - (1-5)
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 0-7 days - (1-5)